Royal Bank of Canada’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-148
Closed 7453
2022
Q3
$0 Buy
+148
New ﹤0.01% 7534
2022
Q2
Sell
-978
Closed -$6K 7414
2022
Q1
$6K Sell
978
-2,605
-73% -$16K ﹤0.01% 6737
2021
Q4
$40K Buy
3,583
+2,053
+134% +$22.9K ﹤0.01% 5972
2021
Q3
$25K Buy
1,530
+455
+42% +$7.44K ﹤0.01% 6069
2021
Q2
$20K Buy
1,075
+347
+48% +$6.46K ﹤0.01% 6073
2021
Q1
$11K Sell
728
-642
-47% -$9.7K ﹤0.01% 6287
2020
Q4
$44K Buy
+1,370
New +$44K ﹤0.01% 5173